tofacitinibbaricitinibTOFBAR
…e Janus kinase inhibitors (JAKi), such as baricitinib (BAR) and tofacitinib (TOF), are oral therapeutic options for rheumatoid arthritis (R…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 1,261–1,320 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
patisiran3pulmonary vasodilators3sulfamethoxazole/trimethoprim3terbinafine3teriflunomide3zoledronate33,4-methylenedioxymethamphetamine3AFP3Amoxicillin–clavulanic acid3Anticancer drugs3Avibactam3Bicarbonate3CCL193CFTR modulators3CTLA-43Cardiovascular drugs3DMSO3Dimethyl fumarate3Domperidone3Dual antiplatelets3Folinic acid3GDF153GM-CSF3Hexavalent chromium (Cr(VI))3Human albumin3Hypochlorous acid3IPACK3IV antibiotics3IVT3Immune checkpoint inhibitors (ICIs)3Janus kinase (JAK) inhibitors3Janus kinase inhibitor3Low-dose atropine3Neurogastroenterol Motil3Oncovin3P2Y123Pharmacotherapies3Psychedelics3STS3Tazobactam3Tigecycline3Tolvaptan3VIA3Vaccine3Vascular endothelial growth factor inhibitors3Vitamin E3Vusolimogene oderparepvec3Yttrium-903Zoledronic acid3abacavir3acenocoumarol3alpha blockers3angiotensin receptor blocker3angiotensin receptor-neprilysin inhibitors3antacids3antiarrhythmic drugs3anticoagulation3antidiabetics3antiepileptics3antiplatelet3
Articles mentioning drugs
10,506 articles · page 12 of 876fosfomycin trometamolvancomycinamoxicillinlinezolidamoxicillin-clavulanatedaptomycinteicoplaninfluoroquinolonescarbapenems
…inolones. For UTIs, 18.65%, 18.18% and 25.68% were treated with fosfomycin trometamol; 16.08%, 13.42% and 11.67% with fluoroquinolones; and 4.82%, 6.…
95.9%
BDP/FF/GB pMDIBUD/FF/GB pMDIFLU/VIL/UMEC DPI
…meter (MMAD) were compared across all active components.Results BDP/FF/GB pMDI demonstrated substantially greater eFPF vs either BUD/FF/GB pMD…
rituximabhydroxychloroquineprednisoloneazathioprineaspirinmycophenolate mofetilmethotrexate
… high-dose corticosteroids, six sessions of plasmapheresis, and rituximab. Due to persistent pancytopenia with febrile neutropenia, empir…
MercaptopurineCarvedilolMycophenolateOmeprazoleBudesonideLamivudineBulevirtideAzathioprineLansoprazoleTacrolimus+8 more
…Immunosuppression 100 (27%)• Azathioprine (38)• Budesonide (7)• Mercaptopurine (5)• Mycophenolate (40)• Prednisolone (4)• Tacrolimus (6) Prima…
nivolumabipilimumab
…ously evaluated in patients with advanced melanoma treated with nivolumab plus ipilimumab. This analysis compared TFS for nivolumab plus …
infliximabadalimumabVedolizumabazathioprineQuantiFERONlevofloxacinrifampicinpyridoxine
…iagnosed with Crohn’s disease at age 10. Initially treated with infliximab, he was switched to adalimumab due to allergic reaction. He did…
ThiopurineAzathioprine
…in Pharmacol. 2024;90:3296–307.Ooi CY, Bohane TD, Lee D, et al. Thiopurine metabolite monitoring in paediatric inflammatory bowel disease.…
FIT-positiveFITFIT-negative
…more negative lower GI investigations in FIT-negative patients (FIT-positive 102 (47.7%), FIT-negative 59 (27.6%)). CRC was diagnosed in 1.4…
midazolamMorphineoctreotidedinoprostoneClonidinedopaminenoradrenalinefurosemideglucagonatracurium+1 more
…isible particles, and degradation products.Conclusion Morphine, midazolam, noradrenaline, dopamine, and clonidine are strong candidates f…
baricitinibabrocitinibdupilumablebrikizumabtralokinumabupadacitinib
…numab 300 mg biweekly; and -44.15% (95% CI -50.44 to -37.86) vs baricitinib 2 mg diary. Statistically significant differences were found be…
ranibizumabafliberceptfaricimabBrolucizumab
…tients (10 injections); faricimab 94 patients (321 injections); ranibizumab 37 patients (127 injections).Classified by most frequent diagno…